Prognostic value of microRNA expression in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
Summary Background Pancreatic ductal adenocarcinoma (PDAC) ranks among the deadliest malignancies, with limited survival benefits despite recent therapeutic advances. Few prognostic biomarkers are available for PDAC monitoring in clinical practice. We conducted a meta-analysis to evaluate and synthesise evidence on the...